Alzheimers disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBI

Conclusions
Plasma p-tau181 is not significantly elevated during the first year after moderate-to-severe TBI and levels do not relate to neuroimaging measures of neurodegeneration.

Source: Journal of Neurology, Neurosurgery and Psychiatry - March 13, 2024 Category: Neurosurgery Authors: Graham, N., Zimmerman, K., Heslegrave, A. J., Keshavan, A., Moro, F., Abed-Maillard, S., Bernini, A., Dunet, V., Garbero, E., Nattino, G., Chieregato, A., Fainardi, E., Baciu, C., Gradisek, P., Magnoni, S., Oddo, M., Bertolini, G., Schott, J. M., Zetterbe Tags: Open access Neurodegeneration Source Type: research